• Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub
  •  0 items - £0.00
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Before Header

  • My account
  •  0 items - £0.00

Action Duchenne

Header Right

  • Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub

News

You are here: Home / News

PTC receives formal dispute resolution request decision from the FDA

20 February 2018 by abzali123

PTC have today announced that the Office of New Drugs of the U.S. Food and Drug Administration has reiterated the FDA's prior …

PTC receives formal dispute resolution request decision from the FDARead More

FDA share guidance for Duchenne and Becker muscular dystrophy drug development

16 February 2018 by abzali123

We are happy to share the news that the U.S. Food and Drug Administration (FDA) have published a guidance document for industry, which details what …

FDA share guidance for Duchenne and Becker muscular dystrophy drug developmentRead More

Summit discuss their recently reported positive data from their ‘PhaseOut DMD’ trial (webinar)

14 February 2018 by abzali123

Download the FAQ Bringing you the most up to date news from the international Duchenne community is one of our core aims.  Action Duchenne and …

Summit discuss their recently reported positive data from their ‘PhaseOut DMD’ trial (webinar)Read More

Catabasis reports Edsalonexent preserved muscle function and slowed progression of Duchenne through more than one year of treatment

13 February 2018 by abzali123

Catabasis have reported new positive efficacy and safety results showing preservation of muscle function and sustained condition-modifying effects in …

Catabasis reports Edsalonexent preserved muscle function and slowed progression of Duchenne through more than one year of treatmentRead More

Capricor receives FDA RMAT designation for CAP-1002

6 February 2018 by abzali123

Capricor have announced that the U.S. Food and Drug Administration (FDA) has granted CAP-1002 the Regenerative Medicine Advanced Therapy (RMAT) …

Capricor receives FDA RMAT designation for CAP-1002Read More

Investigational idebenone becomes available through EAP in US

6 February 2018 by abzali123

Santhera announces the launch of a U.S. Expanded Access Program (EAP) referred to as BreatheDMD with idebenone for patients with DMD. Through the …

Investigational idebenone becomes available through EAP in USRead More

TREAT-NMD steroids analysis demonstrates the power of ‘real-world’ Registry data

2 February 2018 by abzali123

This study underlines the importance of data collection via patient registries and the critical role of multicenter collaboration in the rare disease …

TREAT-NMD steroids analysis demonstrates the power of ‘real-world’ Registry dataRead More

Implementation plans for the UK Strategy for Rare Diseases

30 January 2018 by abzali123

Action Duchenne is delighted to hear the continued commitment by NHS England to improve care of those living with rare diseases. This coincides nicely …

Implementation plans for the UK Strategy for Rare DiseasesRead More

Revised Standards of Care for Duchenne muscular dystrophy

26 January 2018 by abzali123

We are delighted to announce that the revised Standards of Care for Duchenne were published in The Lancet Neurology this week; a high-impact …

Revised Standards of Care for Duchenne muscular dystrophyRead More

Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone® in Duchenne

26 January 2018 by abzali123

On 14 September 2017, the CHMP of the European Medicines Agency (EMA) adopted a negative opinion, recommending the refusal of a change to the …

Santhera Receives Negative CHMP Opinion on Appeal for Authorization of Raxone® in DuchenneRead More

Breaking news – updated Standards of Care published

25 January 2018 by abzali123

Diagnosis and management of Duchenne muscular dystrophy Part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and …

Breaking news – updated Standards of Care publishedRead More

Positive data from Summit’s PhaseOUT DMD ezutromid clinical trial

25 January 2018 by abzali123

 Increase in utrophin protein expression observed Summit accelerating preparations for pivotal clinical trial Ezutromid is a potential …

Positive data from Summit’s PhaseOUT DMD ezutromid clinical trialRead More

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • Page 47
  • Interim pages omitted …
  • Page 49
  • Go to Next Page »

Footer

Action Duchenne
2nd Floor
South
One Castle Park
Tower Hill
Bristol
BS2 OJA

0300 102 1762
info@actionduchenne.org 

 

 

 

 

 

 

 

 

Subscribe to our mailing list

Do you consent to receiving regular email updates? *
Email Format
  • Accessibility
  • Privacy Policy
  • Terms & Conditions

Site Footer

Fundraising Regulator badge with validation link

© Action Duchenne - Registered Charity No 1101971 - Scottish Charity No SC043852